{"cik":"0001674416","ticker":"CRSP","name":"CRISPR Therapeutics AG","sic_code":"2836","sic_description":"Biological Products, (No Diagnostic Substances)","exchange":"Nasdaq","state_of_incorporation":"V8","fiscal_year_end":"1231","first_filing_date":"2026-05-14","last_filing_date":"2026-08-11","url":"/sec/cik-0001674416","insider_summary":{"total_transactions":17,"unique_insiders":13,"latest_transaction":"2026-08-07"},"recent_filings":[{"accession_number":"0001193125-26-423057","form_type":"4","form_type_family":"insider","doc_date":"2026-10-15","title":"4 — CRISPR Therapeutics AG — 2026-10-15","url_slug":"/sec/cik-0001674416/4/0001193125-26-423057","edgar_url":"https://www.sec.gov/Archives/edgar/data/1674416/0001193125-26-423057-index.html"},{"accession_number":"0001193125-26-423056","form_type":"4","form_type_family":"insider","doc_date":"2026-10-15","title":"4 — CRISPR Therapeutics AG — 2026-10-15","url_slug":"/sec/cik-0001674416/4/0001193125-26-423056","edgar_url":"https://www.sec.gov/Archives/edgar/data/1674416/0001193125-26-423056-index.html"},{"accession_number":"0001193125-26-418101","form_type":"4","form_type_family":"insider","doc_date":"2026-10-08","title":"4 — CRISPR Therapeutics AG — 2026-10-08","url_slug":"/sec/cik-0001674416/4/0001193125-26-418101","edgar_url":"https://www.sec.gov/Archives/edgar/data/1674416/0001193125-26-418101-index.html"},{"accession_number":"0001950047-26-010087","form_type":"144","form_type_family":"other","doc_date":"2026-10-06","title":"144 — CRISPR Therapeutics AG — 2026-10-06","url_slug":"/sec/cik-0001674416/144/0001950047-26-010087","edgar_url":"https://www.sec.gov/Archives/edgar/data/1674416/0001950047-26-010087-index.html"},{"accession_number":"0001193125-26-401237","form_type":"4","form_type_family":"insider","doc_date":"2026-09-24","title":"4 — CRISPR Therapeutics AG — 2026-09-24","url_slug":"/sec/cik-0001674416/4/0001193125-26-401237","edgar_url":"https://www.sec.gov/Archives/edgar/data/1674416/0001193125-26-401237-index.html"},{"accession_number":"0001950047-26-009755","form_type":"144","form_type_family":"other","doc_date":"2026-09-22","title":"144 — CRISPR Therapeutics AG — 2026-09-22","url_slug":"/sec/cik-0001674416/144/0001950047-26-009755","edgar_url":"https://www.sec.gov/Archives/edgar/data/1674416/0001950047-26-009755-index.html"},{"accession_number":"0000940594-26-000049","form_type":"SCHEDULE 13G/A","form_type_family":"other","doc_date":"2026-08-14","title":"SCHEDULE 13G/A — CRISPR Therapeutics AG — 2026-08-14","url_slug":"/sec/cik-0001674416/schedule-13g-a/0000940594-26-000049","edgar_url":"https://www.sec.gov/Archives/edgar/data/1674416/0000940594-26-000049-index.html"},{"accession_number":"0001193125-26-345111","form_type":"4","form_type_family":"insider","doc_date":"2026-08-11","title":"4 — CRISPR Therapeutics AG — 2026-08-11","url_slug":"/sec/cik-0001674416/4/0001193125-26-345111","edgar_url":"https://www.sec.gov/Archives/edgar/data/1674416/0001193125-26-345111-index.html"},{"accession_number":"0001193125-26-330644","form_type":"8-K","form_type_family":"current","doc_date":"2026-08-03","title":"8-K — CRISPR Therapeutics AG — 2026-08-03","url_slug":"/sec/cik-0001674416/8-k/0001193125-26-330644","edgar_url":"https://www.sec.gov/Archives/edgar/data/1674416/0001193125-26-330644-index.html"},{"accession_number":"0001193125-26-330672","form_type":"10-Q","form_type_family":"quarterly","doc_date":"2026-08-03","title":"10-Q — CRISPR Therapeutics AG — 2026-08-03","url_slug":"/sec/cik-0001674416/10-q/0001193125-26-330672","edgar_url":"https://www.sec.gov/Archives/edgar/data/1674416/0001193125-26-330672-index.html"},{"accession_number":"0002012383-26-002146","form_type":"SCHEDULE 13G/A","form_type_family":"other","doc_date":"2026-07-27","title":"SCHEDULE 13G/A — CRISPR Therapeutics AG — 2026-07-27","url_slug":"/sec/cik-0001674416/schedule-13g-a/0002012383-26-002146","edgar_url":"https://www.sec.gov/Archives/edgar/data/1674416/0002012383-26-002146-index.html"},{"accession_number":"0001193125-26-264282","form_type":"4","form_type_family":"insider","doc_date":"2026-06-09","title":"4 — CRISPR Therapeutics AG — 2026-06-09","url_slug":"/sec/cik-0001674416/4/0001193125-26-264282","edgar_url":"https://www.sec.gov/Archives/edgar/data/1674416/0001193125-26-264282-index.html"},{"accession_number":"0001193125-26-264279","form_type":"4","form_type_family":"insider","doc_date":"2026-06-09","title":"4 — CRISPR Therapeutics AG — 2026-06-09","url_slug":"/sec/cik-0001674416/4/0001193125-26-264279","edgar_url":"https://www.sec.gov/Archives/edgar/data/1674416/0001193125-26-264279-index.html"},{"accession_number":"0001193125-26-264289","form_type":"4","form_type_family":"insider","doc_date":"2026-06-09","title":"4 — CRISPR Therapeutics AG — 2026-06-09","url_slug":"/sec/cik-0001674416/4/0001193125-26-264289","edgar_url":"https://www.sec.gov/Archives/edgar/data/1674416/0001193125-26-264289-index.html"},{"accession_number":"0001193125-26-258473","form_type":"S-8","form_type_family":"other","doc_date":"2026-06-05","title":"S-8 — CRISPR Therapeutics AG — 2026-06-05","url_slug":"/sec/cik-0001674416/s-8/0001193125-26-258473","edgar_url":"https://www.sec.gov/Archives/edgar/data/1674416/0001193125-26-258473-index.html"},{"accession_number":"0001193125-26-257593","form_type":"8-K","form_type_family":"current","doc_date":"2026-06-04","title":"8-K — CRISPR Therapeutics AG — 2026-06-04","url_slug":"/sec/cik-0001674416/8-k/0001193125-26-257593","edgar_url":"https://www.sec.gov/Archives/edgar/data/1674416/0001193125-26-257593-index.html"},{"accession_number":"0001193125-26-253929","form_type":"4","form_type_family":"insider","doc_date":"2026-06-02","title":"4 — CRISPR Therapeutics AG — 2026-06-02","url_slug":"/sec/cik-0001674416/4/0001193125-26-253929","edgar_url":"https://www.sec.gov/Archives/edgar/data/1674416/0001193125-26-253929-index.html"},{"accession_number":"0001193125-26-253926","form_type":"4","form_type_family":"insider","doc_date":"2026-06-02","title":"4 — CRISPR Therapeutics AG — 2026-06-02","url_slug":"/sec/cik-0001674416/4/0001193125-26-253926","edgar_url":"https://www.sec.gov/Archives/edgar/data/1674416/0001193125-26-253926-index.html"},{"accession_number":"0001193125-26-253925","form_type":"4","form_type_family":"insider","doc_date":"2026-06-02","title":"4 — CRISPR Therapeutics AG — 2026-06-02","url_slug":"/sec/cik-0001674416/4/0001193125-26-253925","edgar_url":"https://www.sec.gov/Archives/edgar/data/1674416/0001193125-26-253925-index.html"},{"accession_number":"0001193125-26-251817","form_type":"4","form_type_family":"insider","doc_date":"2026-06-01","title":"4 — CRISPR Therapeutics AG — 2026-06-01","url_slug":"/sec/cik-0001674416/4/0001193125-26-251817","edgar_url":"https://www.sec.gov/Archives/edgar/data/1674416/0001193125-26-251817-index.html"},{"accession_number":"0000940594-26-000027","form_type":"SCHEDULE 13G/A","form_type_family":"other","doc_date":"2026-05-15","title":"SCHEDULE 13G/A — CRISPR Therapeutics AG — 2026-05-15","url_slug":"/sec/cik-0001674416/schedule-13g-a/0000940594-26-000027","edgar_url":"https://www.sec.gov/Archives/edgar/data/1674416/0000940594-26-000027-index.html"}],"related_endpoints":{"profile":"/sec/CRSP/profile","timeline":"/sec/CRSP/timeline","peers":"/sec/CRSP/peers","insider_pulse":"/sec/CRSP/insider-pulse","insider_summary":"/sec/CRSP/insider-summary","insider_transactions":"/sec/CRSP/insider-transactions","form144":"/sec/CRSP/form144","holdings_as_filer":"/sec/CRSP/holdings","financial_facts":"/sec/CRSP/financial-facts","derivatives":"/sec/CRSP/derivatives","officers":"/sec/CRSP/officers","insider_network":"/sec/CRSP/insider-network","risk_flags":"/sec/CRSP/risk-flags","filings":"/sec/CRSP/filings","cross_topic_dossier":"/api/v1/dossier?ticker=CRSP"}}